Page last updated: 2024-12-05

2,3,4,6-tetrachlorophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3,4,6-tetrachlorophenol: RN given refers to parent cpd; see also record for tetrachlorophenol with locants for chloro groups not specified [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,3,4,6-tetrachlorophenol : A tetrachlorophenol in which the chlorines are located at positions 2, 3, 4, and 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6028
CHEMBL ID320361
CHEBI ID132359
SCHEMBL ID54380
MeSH IDM0098892

Synonyms (56)

Synonym
chlorophenols
1-hydroxy-2,4,6-tetrachlorobenzene
nsc-2428
phenol,3,4,6-tetrachloro-
wln: qr bg cg dg fg
58-90-2
nsc2428
2,4,6-tetrachlorophenol
dowicide 6
phenol, 2,3,4,6-tetrachloro-
NCGC00091890-01
2,3,4,6-tetrachlorophenol
inchi=1/c6h2cl4o/c7-2-1-3(8)6(11)5(10)4(2)9/h1,11
rcra waste number u212
ai3-00073
nsc 2428
1-hydroxy-2,3,4,6-tetrachlorobenzene
brn 0779754
rcra waste no. u212
hsdb 1338
2,4,5,6-tetrachlorophenol
einecs 200-402-8
ccris 2512
2,3,4,6-tetrachlorophenol, analytical standard
NCGC00091890-02
2,3,4,6-tecp
CHEBI:132359
CHEMBL320361
2,3,4,6-tetrachloro-phenol
2,4,5,6-tetrachlorophenol-13c6
T0068
NCGC00091890-03
tox21_302932
cas-58-90-2
dtxsid9021716 ,
NCGC00256521-01
dtxcid201716
NCGC00259480-01
tox21_201931
4-06-00-01021 (beilstein handbook reference)
unii-2442s914fx
ky 5
2442s914fx ,
2,3,4,6-tetrachlorophenate
2,4,5,6-tetrachlorophenol (contains 10% pentachlorophenol)
FT-0609359
AKOS015888275
SCHEMBL54380
2,3,4,6-tetrachlorophenol [hsdb]
2,3,4,6-tetrachlorophenol, vial of 1 g, analytical standard
2,3,4,6-tetrachlorophenol 100 microg/ml in methanol
2,3,4,6-tetrachlorophenol 10 microg/ml in cyclohexane
2,3,4,6-tetrakis(chloranyl)phenol
Q22051085
2,3,4,6-tetrachlorophenol 1000 microg/ml in methanol
2,4,5,6-tetrachlorophenol (contains 10per cent pentachlorophenol)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Therefore, an inhibitory effect on the Ca(2+)-transport-ATPase indicates a toxic effect of these compounds to cell functions."( The Ca(2+)-transport-ATPase of human erythrocytes as an in vitro toxicity test system--acute effects of some chlorinated compounds.
Janik, F; Wolf, HU, 1992
)
0.28
", those chemicals which resulted in an early toxic endpoint at the lowest whole-log concentration in the adult hydra assay)."( Evaluation of the developmental toxicity of chlorinated phenols utilizing Hydra attenuata and postimplantation rat embryos in culture.
Clement, BA; Mayura, K; Phillips, TD; Smith, EE, 1991
)
0.28
" Toxic effects were observed only at the 10 mg/kg dose in the tPCP-treated calves."( Assessment of pentachlorophenol toxicity in newborn calves: clinicopathology and tissue residues.
Forsell, JH; Hughes, BJ; Kuo, C; Shull, LR; Sleight, SD, 1985
)
0.27
"Acute oral LD50 values were determined for 2-, 3-, and 4-chlorophenol, 2,3-, 2,4-, 2,5-, 2,6-, 3,4-, and 3,5 dichlorophenol and pentachlorophenol in male and female mice."( Acute toxicity of monochlorophenols, dichlorophenols and pentachlorophenol in the mouse.
Borzelleca, JF; Condie, LW; Egle, JL; Hayes, JR, 1985
)
0.27
" Previous studies have demonstrated the adverse effects of CPs on embryonic and fetal development."( Developmental toxicity and structure-activity relationships of chlorophenols using human embryonic palatal mesenchymal cells.
Burghardt, RC; Hutchinson, RW; Lewis, RP; Mayura, K; Phillips, TD; Zhao, F, 1995
)
0.29
" The previous empirical experience that the toxicity of chlorinated phenol derivatives will increase with a growing degree of chlorination and that the presence of the methoxy group will cause a lowering of the toxic effect was demonstrated."( Application of the exploratory data analysis for evaluating the toxicity of chlorinated phenol derivatives by various cell models.
Cernáková, M; Jurásek, P, 1994
)
0.29
" The toxic process might also be mediated by glutathione (GSH) conjugates of ADCP, as suggested for the mechanism of 4-aminophenol nephrotoxicity."( 4-Amino-2,6-dichlorophenol nephrotoxicity in the Fischer 344 rat: protection by ascorbic acid, AT-125, and aminooxyacetic acid.
Anestis, DK; Ball, JG; Brown, PI; Hong, SK; Rankin, GO; Valentovic, MA, 1997
)
0.3
" The results of regression analysis showed that log Kow is the most successful descriptor, indicating that the ability of chlorophenols to partition into the lipid bilayer of the mitochondrial membrane has an important role in determining their toxic effects."( Quantitative structure-activity relationships for the toxicity of chlorophenols to mammalian submitochondrial particles.
Argese, E; Bettiol, C; Giurin, G; Miana, P, 1999
)
0.3
" These results indicate that partial life-cycle toxicity tests are not sufficiently sensitive to detect ecologically relevant adverse effects."( Full life-cycle toxicity assessment using rotifer resting egg production: implications for ecological risk assessment.
Preston, BL; Snell, TW, 2001
)
0.31
" These findings indicate that 2A45CP is directly toxic to renal cortical slices and that cytotoxicity is at least partially mediated by a reactive intermediate."( Characterization of 2-amino-4,5-dichlorophenol (2A45CP) in vitro toxicity in renal cortical slices from male Fischer 344 rats.
Ball, JG; Rankin, GO; Sun, H; Valentovic, MA, 2002
)
0.31
" The toxic response to 3,5-DCP in model and domestic activated sludge was shown to be dependent on sludge solid concentration (measured as total suspended solids, gTSS(-1)."( An ATP luminescence method for direct toxicity assessment of pollutants impacting on the activated sewage sludge process.
Christofi, N; Dalzell, DJ, 2002
)
0.31
" While multiple exposure is widely acknowledged, arguments are raised that adverse combined effects might not be evoked by mixtures of substances with dissimilar modes of action and being present at only low concentrations."( Mixture toxicity of priority pollutants at no observed effect concentrations (NOECs).
Altenburger, R; Consolaro, F; Gramatica, P; Scholze, M; Walter, H, 2002
)
0.31
"9 micromol/g wet weight for 2,4,5-TCP and PCP, respectively, demonstrating the usefulness of this method for accurate, and more comparable, measurement of toxicity of chemicals with the same mode of toxic action in varying conditions."( Toxicokinetics, toxicity and lethal body residues of two chlorophenols in the oligochaete worm, Lumbriculus variegatus, in different sediments.
Halme, A; Kukkonen, JV; Nikkilä, A, 2003
)
0.32
"Chlorophenols, mainly used as biocides, are compounds with a wide spectrum of toxic effects, including teratogenic and carcinogenic actions."( Involvement of oxidative sress in the toxicity of 4-monochlorophenol in Hep G2 cells in culture.
Colein, P; Garçon, G; Grave-Descampiaux, B; Hannothiaux, MH; Shirali, P; Truffin, D,
)
0.13
" Comparison of EC(50) data obtained with the two methods shows that in both cases 3,5-dichlorophenol is more toxic than other compounds investigated and dichloromethane has a very low toxicity value."( Toxicity assessment of common xenobiotic compounds on municipal activated sludge: comparison between respirometry and Microtox.
Laera, G; Ramadori, R; Ricco, G; Tomei, MC, 2004
)
0.32
"The toxic effects of photoproducts formed upon the photolysis of 2- and 4-chlorophenol (CP) frozen solutions in polycrystalline ice phase were determined with a bacterial luminescence test (Vibrio fisheri), and in vitro biomarker assay for dioxin-like effects (inductions of AhR-dependent luciferase in H4IIE-luc cells) and compared to the toxic effects of products of the same photoreaction in aquatic phase."( Toxicity increases in ice containing monochlorophenols upon photolysis: environmental consequences.
Bláha, L; Janosek, J; Klán, P; Klánová, J; Růzicka, R; Skarek, M, 2004
)
0.32
" These results not only demonstrate that L929 cell growth inhibition bioassay may be useful to provide the comparative evaluation of toxicity of CPs in vitro, but also implicate that CP, DCP, TCP, in comparison with PCP, can induce L929 cell death by apoptosis, resulting in lower procarcinogensis, which may help to elucidate the molecular basis for the adverse health effects associated with CPs exposure."( Cytotoxic effects of environmentally relevant chlorophenols on L929 cells and their mechanisms.
Chen, J; Jiang, J; Yu, H; Zhang, F; Zhang, J, 2004
)
0.32
" To supplement the safety test data on these ingredients, available data on related ingredients (4-amino-2-hydroxytoluene and p-,m-, and o-aminophenol) previously found safe as used by the Cosmetic Ingredient Review (CIR) Expert Panel were summarized."( Final report on the safety assessment of 6-Amino-m-Cresol, 6-Amino-o-Cresol, 4-Amino-m-Cresol, 5-Amino-4-Chloro-o-Cresol, 5-Amino-6-Chloro-o-Cresol, and 4-Chloro-2-Aminophenol.
, 2004
)
0.32
" In addition, ozonated 3-CP and 4-CP also significantly induced new aqueous toxicity, if these toxic intermediates were not further ozonated."( Toxicity measurements in aqueous solution during ozonation of mono-chlorophenols.
Chang, CH; Liou, ML; Ma, HW; Shang, NC; Yu, YH, 2006
)
0.33
"Chlorinated phenolic compounds present in some chemical industry wastewaters cause severe toxic effects on the organisms and often are resistant to biological degradation."( COD, para-chlorophenol and toxicity removal from para-chlorophenol containing synthetic wastewater in an activated sludge unit.
Kargi, F; Konya, I, 2006
)
0.33
" In such cases, the adverse neurologic consequences have been presumed to result from a direct toxic effect of this small, organic molecule."( Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity.
Cheong, R; Cortese, IC; Newman-Toker, DE; Wilson, RK, 2006
)
0.33
" The transpiration of the trees was used to determine toxic effects."( Uptake, accumulation, phytotoxicity, and removal of 2,4-dichlorophenol in willow trees.
Kusk, KO; Trapp, S; Ucisik, AS, 2007
)
0.34
" The transpiration of the trees was used to determine toxic effects."( Uptake, removal, accumulation, and phytotoxicity of 4-chlorophenol in willow trees.
Trapp, S; Ucisik, AS, 2008
)
0.35
" Percent toxicity removals were always lower than TCP removals indicating presence or formation of some toxic by products from TCP biodegradation."( COD, 2,4,6-trichlorophenol (TCP) and toxicity removal from synthetic wastewater in a rotating perforated-tubes biofilm reactor.
Eker, S; Kargi, F, 2008
)
0.35
"Sometimes, urban wastewaters convey a more or less significant part of toxic products from industries or the craft industry."( Characterization of the toxic effects of cadmium and 3.5-dichlorophenol on nitrifying activity and mortality in biologically activated sludge systems-effect of low temperature.
Marquot, A; Pambrun, V; Racault, Y, 2008
)
0.35
" Studies realized at low temperature confirmed this assumption, and put in evidence the effect of temperature on toxic substances capable of being biosorbed."( Characterization of the toxic effects of cadmium and 3.5-dichlorophenol on nitrifying activity and mortality in biologically activated sludge systems-effect of low temperature.
Marquot, A; Pambrun, V; Racault, Y, 2008
)
0.35
" The experiments lead to the determination of the IC50 values for both toxic substances on biological nitrification."( Characterization of the toxic effects of cadmium and 3.5-dichlorophenol on nitrifying activity and mortality in biologically activated sludge systems-effect of low temperature.
Marquot, A; Pambrun, V; Racault, Y, 2008
)
0.35
" Finally, these first results show that toxic substances can have an effect on the growth rate but also on the decay rate, depending on the characteristics of the toxic substance and the sludge."( Characterization of the toxic effects of cadmium and 3.5-dichlorophenol on nitrifying activity and mortality in biologically activated sludge systems-effect of low temperature.
Marquot, A; Pambrun, V; Racault, Y, 2008
)
0.35
" The presence of 300 mg l(-1) rhamnolipids, that is at about twice their critical micelle concentration (CMC), increased the EC50 of phenol, 4-chlorophenol, 2,4-dichlorophenol and 2,4,5-trichlorophenol by about 12, 19, 32 and 40%, respectively, and consequently reduced the bioavailability and the freely dissolved concentration of the toxic phenolic compounds."( Rhamnolipid biosurfactants decrease the toxicity of chlorinated phenols to Pseudomonas putida DOT-T1E.
Chrzanowski, L; Heipieper, HJ; Kaestner, M; Meulenkamp, R; Wick, LY, 2009
)
0.35
" Accordingly, a direct toxicity assessment (DTA) based on chronoamperometry was proposed to detect the effect of toxic chemicals on microorganisms."( Direct toxicity assessment of toxic chemicals with electrochemical method.
Dong, S; Liu, C; Sun, T; Xu, X, 2009
)
0.35
" Consequently, the SASS may be recommended as a promising configuration alternative for the waste streams containing toxic compounds."( Reducing effect of aerobic selector on the toxicity of synthetic organic compounds in activated sludge process.
Alkan, U; Eleren, SC, 2009
)
0.35
" The fungicides thiram, captan, and benomyl, and to a lesser extent fenpropimorph and propiconazole had quantifiable toxic effects on leucine incorporation, with EC(50) values ranging from 3 to 70 mg l(-1), while carbendazim, carboxin, and cycloheximide had little effect at the investigated concentrations."( Toxicity of fungicides to natural bacterial communities in wetland water and sediment measured using leucine incorporation and potential denitrification.
Bååth, E; Berglund, O; Lindgren, PE; Milenkovski, S, 2010
)
0.36
" High feed 4-CP contents adversely affected the system performance due to toxic effects of 4-CP on microorganisms."( COD, para-chlorophenol and toxicity removal from synthetic wastewater using rotating tubes biofilm reactor (RTBR).
Eker, S; Kargi, F, 2010
)
0.36
" In general, herbicides showed lower inhibition, being alachlor the less toxic from this criterion."( Comparison of experimental methods for determination of toxicity and biodegradability of xenobiotic compounds.
Mohedano, AF; Polo, AM; Rodríguez, JJ; Sanchis, S; Tobajas, M, 2011
)
0.37
" Toxicity assessment on algae indicates that treated solutions of 2,4-dichlorophenol are less toxic on algae Pseudokirchneriella subcapitata if compared to not treated solutions whereas in the case of 3,4-dichlorophenol only the samples collected during the runs at 20 and 60 min are capable of inhibiting the growth of the adopted organism."( Oxidation of 2,4-dichlorophenol and 3,4-dichlorophenol by means of Fe(III)-homogeneous photocatalysis and algal toxicity assessment of the treated solutions.
Andreozzi, R; Di Somma, I; Marotta, R; Pinto, G; Pollio, A; Spasiano, D, 2011
)
0.37
" This is the least toxic pollutant assayed."( Ecotoxicity of chlorophenolic compounds depending on soil characteristics.
Cáliz, J; Cruañas, R; Garau, MA; Martí, E; Montserrat, G; Sierra, J; Vila, X, 2011
)
0.37
" Intermediates products were all less toxic than 4-chlorophenol and a significant removal of the overall toxicity was accomplished."( Photocatalytic degradation of 4-chlorophenol under P-modified TiO2/UV system: kinetics, intermediates, phytotoxicity and acute toxicity.
Elghniji, K; Hentati, O; Ksibi, M; Mahfoudh, A; Mlaik, N, 2012
)
0.38
" The non-chemical technologies showed advantages in terms of complete (in the case of adsorption) or easy (enzymatic treatments) removal of toxic treatment by-products."( Removal efficiency and toxicity reduction of 4-chlorophenol with physical, chemical and biochemical methods.
Christofi, N; Dams, R; Gómez, E; Gómez, JL; Gómez, M; Murcia, MD,
)
0.13
" Consequently, the toxic activity of the test compounds was controlled by electrophilic index and electronic properties."( Dechlorination of chlorinated compounds by Trametes versicolor ATCC 200801 crude laccase and quantitative structure-activity relationship of toxicity.
Aytar, P; Çabuk, A; Gedikli, S; Sidir, İ; Sidir, YG, 2012
)
0.38
" coli after being incubated for 3 hr with the toxic compound in buffer solutions."( Toxicity detection of sodium nitrite, borax and aluminum potassium sulfate using electrochemical method.
Dong, S; Yong, D; Yu, D, 2013
)
0.39
" oblignus; while nitrobenzene was only moderately toxic to both species of microalgae."( [Acute toxicity of three typical pollutants to aquatic organisms and their water quality criteria].
Cui, YB; Jiang, DS; Li, M; Shi, XR, 2014
)
0.4
" Yield-based estimates did not confirm this pattern and potassium dichromate was one order of magnitude more toxic than 3,5-dichlorophenol."( Toxicity testing with the benthic diatom Navicula libonensis (Schoeman 1970): procedure optimisation and assessment of the species sensitivity to reference chemicals.
Abrantes, N; Almeida, SF; Gonçalves, F; Pereira, JL; Soares, AM; Vidal, T, 2014
)
0.4
" The mechanism of chloroaniline nephrotoxicity may occur via more than one mechanism, but aminochlorophenol metabolites appear to contribute to the adverse in vivo effects."( 4-Amino-2-chlorophenol: Comparative in vitro nephrotoxicity and mechanisms of bioactivation.
Anestis, DK; Ferguson, T; Preston, D; Racine, C; Rankin, GO; Sweeney, A, 2014
)
0.4
"Here, we present a new toxicity bioassay (CO2-TOX), able to detect toxic or inhibitory compounds in water samples, based on the quantification of Pseudomonas putida KT2440 CO2 production."( A new P. putida instrumental toxicity bioassay.
Abrevaya, XC; Cortón, E; Figueredo, F, 2015
)
0.42
" Based on the existing knowledge and in order to move a step forward, the purpose of this study is to investigate the toxic and mainly the genotoxic effects of 2-CP using a combination of bioassays."( Evaluation of toxicity and genotoxicity of 2-chlorophenol on bacteria, fish and human cells.
Antonopoulou, M; Konstantinou, I; Vlastos, D, 2016
)
0.43
" Binary mixture tests were conducted using proportions of the respective IC50s in terms of toxic unit (TU)."( Single and mixture toxicity of pharmaceuticals and chlorophenols to freshwater algae Chlorella vulgaris.
Geiger, E; Hornek-Gausterer, R; Saçan, MT, 2016
)
0.43
"Tetrabromobisphenol A and tetrachlorobisphenol A are halogenated bisphenol A (H-BPA), and has raised concerns about their adverse effects on the development of fetuses and infants, however, the molecular mechanisms are unclear, and related metabolomics studies are limited."( Metabolomics approach reveals metabolic disorders and potential biomarkers associated with the developmental toxicity of tetrabromobisphenol A and tetrachlorobisphenol A.
Chen, Y; Chi, Y; Dong, S; Huang, Q; Lin, Y; Wang, HO; Ye, G; Ye, T, 2016
)
0.43
"2,4-Dichlorophenol (2,4-DCP) is an environmental pollutant exhibiting a wide spectrum of toxic effects."( Endoplasmic reticulum stress is involved in 2,4-dichlorophenol-induced hepatotoxicity.
Chen, P; Fu, J; Zhang, X; Zhang, Y, 2016
)
0.43
" These compounds are not readily degraded naturally, and easily accumulate in organs, tissues and cells via food chains, further leading to acute and chronic toxic effects on aquatic organisms."( The toxic effects of chlorophenols and associated mechanisms in fish.
Ge, T; Gu, X; Han, J; Huang, D; Ma, L; Naeem, S; Qi, Y; Zhang, C, 2017
)
0.46
" However, its toxic effects on animals and humans are not fully understood."( The Toxic Effects of Tetrachlorobisphenol A in Saccharomyces cerevisiae Cells via Metabolic Interference.
Ji, Z; Li, H; Song, M; Tian, J; Wang, F, 2017
)
0.46
"Toxicity assessment of water is of great important to the safety of human health and to social security because of more and more toxic compounds that are spilled into the aquatic environment."( Bioelectrochemical biosensor for water toxicity detection: generation of dual signals for electrochemical assay confirmation.
Fang, Z; Wang, YZ; Yang, Y; Yong, YC; Yu, YY, 2018
)
0.48
"It is well established that aquatic wildlife in marine and freshwater of the European Union is exposed to natural and synthetic endocrine disruptor compounds (EDCs) which are able to interfere with the hormonal system causing adverse effects on the intact physiology of organisms."( Toxicity of aqueous mixture of phenol and chlorophenols upon photosensitized oxidation initiated by sunlight or vis-lamp.
Drozdek, E; Foszpańczyk, M; Gmurek, M; Ledakowicz, S, 2018
)
0.48
"Tetrachlorobisphenol A (TCBPA), which is widely used as flame retardant, can be released into various environments, thereby being absorbed by wildlife or human beings through food chain's bio-magnification and causing some adverse influences on wildlife or human beings."( Oxidative stress and cytotoxicity induced by tetrachlorobisphenol A in Saccharomyces cerevisiae cells.
Ji, Z; Li, H; Song, M; Tian, J; Wang, F; Zhang, Y, 2018
)
0.48
"Tetrabromobisphenol A (TBBPA) and tetrachlorobisphenol A (TCBPA) are persistent toxic environmental pollutants that cause severe reproductive toxicity in animals."( Differences in reproductive toxicity of TBBPA and TCBPA exposure in male Rana nigromaculata.
Chen, B; Chen, F; Du, Q; He, J; Jia, X; Li, N; Liu, W; Shan, X; Tang, J; Zhang, H, 2018
)
0.48
" Considering the acute toxicity evolution under different conditions and profiles of acute toxicity in HPLC fractions, the highly toxic intermediates probably included same non-chlorine carboxylic acids though the three CPs had different substituent positions with higher polarity than their parent compounds."( Acute toxicity evolution during ozonation of mono-chlorophenols and initial identification of highly toxic intermediates.
Ma, D; Shen, J; Wang, L; Wei, J; Zhang, H; Zhang, P; Zhou, Y, 2019
)
0.51
" In addition, antioxidant activity of CNCP was evaluated and its safe dose was identified."( In vivo acute toxicity and anti-gastric evaluation of a novel dichloro Schiff base: Bax and HSP70 alteration.
Hussaini, J; Khalilzadeh, M; Majid, NA; Rad, SK; Saremi, K, 2020
)
0.56
"0%) discontinued, most commonly due to adverse events (n = 137) and consent withdrawn for reason other than adverse event (n = 74); 1339 patients received ≥1 treatment dose (median modal dose = 200 mg)."( Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
Aboumatar, S; Borchert, L; Gelfand, M; Halford, JJ; Kamin, M; Klein, P; Krauss, GL; Rosenfeld, WE; Sperling, MR; Vossler, DG; Wechsler, R, 2020
)
0.56
"Biological safety evaluation and toxic by-products identification are critical issues in the partial oxidation process."( New insight into increased toxicity during ozonation of chlorophenol: The significant contribution of oxidizing intermediates.
Li, J; Liu, X; Ma, D; Ma, X; Shen, J; Sheng, Q; Sun, X; Wang, L; Wei, J; Zheng, M, 2021
)
0.62
" We calculated the risk ratio (RR) of ≥50%, ≥75% and 100% reduction in seizure frequency from baseline, as well as dropout and serious adverse events related to treatment."( Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
Wang, C; Wang, J; Zhang, L, 2021
)
0.62
" Cenobamate could be well tolerated, the most common adverse events associated with cenobamate were dizziness, somnolence, fatigue, headache and nausea."( Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
Wang, C; Wang, J; Zhang, L, 2021
)
0.62
" Safety assessments included frequency of treatment-emergent adverse events (TEAEs) and serious TEAEs, TEAE severity, and TEAEs leading to discontinuation."( Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
Chung, SS; French, JA; Kamin, M; Krauss, GL; Lee, SK; Maciejowski, M; Rosenfeld, WE; Sperling, MR, 2021
)
0.62
"5%, 29/149), adverse event (10."( Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
Chung, SS; French, JA; Kamin, M; Krauss, GL; Lee, SK; Maciejowski, M; Rosenfeld, WE; Sperling, MR, 2021
)
0.62
" Treatment-emergent adverse events (TEAEs) were examined in the double-blind period."( Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.
Brandt, C; Milanov, I; Sánchez-Álvarez, JC; Serratosa, JM; Steinhoff, BJ, 2022
)
0.72
" This study reveals the toxic effects of halophenolic DBPs on mammalian liver and provides novel insights into the underlying mechanisms of hepatotoxicity."( In vivo toxicity evaluations of halophenolic disinfection byproducts in drinking water: A multi-omics analysis of toxic mechanisms.
Jiang, L; Jiang, X; Pan, Y; Qiu, J; Shi, P; Xu, B; Zhou, Q, 2022
)
0.72
" This post hoc analysis reports onset of efficacy and characterizes time to onset, duration, and severity of the most common treatment-emergent adverse events (TEAEs) during cenobamate titration."( Onset of efficacy and adverse events during Cenobamate titration period.
Ben-Menachem, E; Brandt, C; García Morales, I; Rosenfeld, WE; Santamarina, E; Serratosa, JM; Steinhoff, BJ, 2022
)
0.72
" Long-term treatment with adjunctive cenobamate was generally safe and well-tolerated."( Onset of efficacy and adverse events during Cenobamate titration period.
Ben-Menachem, E; Brandt, C; García Morales, I; Rosenfeld, WE; Santamarina, E; Serratosa, JM; Steinhoff, BJ, 2022
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
"A pharmacokinetic study of an intentional pentachlorophenol ingestion by an elderly human has been undertaken."( A pharmacokinetic study of pentachlorophenol poisoning and the effect of forced diuresis.
Haley, TJ; Young, JF, 1978
)
0.26
" Based on first-order elimination kinetics an elimination half-life of 20 days was derived."( Pharmacokinetics of pentachlorophenol in man.
Schlatter, C; Schmid, P; Uhl, S, 1986
)
0.27
" Pharmacokinetic data suggest that fengabine may induce its own metabolism following repeated dosing."( A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers.
Fairweather, DB; Hilton, S; Hindmarch, I; Kerr, JS, 1993
)
0.29
" Chemical classification, structure, mechanism of action, pharmacokinetic data and therapeutic ranges for total and free fractions and interactions were collected."( New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs).
Główka, FK; Karaźniewcz-Łada, M; Sommerfeld-Klatta, K; Zielińska-Psuja, B, 2020
)
0.56
"Report insights into the pharmacokinetic and pharmacodynamic interaction between cenobamate (CNB) and clobazam (CLB), derived from data in patients enrolled at our center in a global multicenter open-label safety study of CNB."( The cenobamate-clobazam interaction- evidence of synergy in addition to pharmacokinetic interaction.
Abou-Khalil, B; Osborn, M, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"A method for the determination of chlorophenols in soil samples using accelerated solvent extraction (ASE) with water as the solvent combined with solid-phase microextraction (SPME) and GC/MS has been developed."( Determination of chlorophenols in soils using accelerated solvent extraction combined with solid-phase microextraction.
Möder, M; Popp, P; Wennrich, L, 2000
)
0.31
"The aim of this study was to investigate in vitro the antimicrobial activity of calcium hydroxide [Ca(OH)2] in combination with different vehicles against endodontic pathogens."( In vitro evaluation of the susceptibility of endodontic pathogens to calcium hydroxide combined with different vehicles.
de Souza Filho, FJ; Ferraz, CC; Gomes, BP; Sena, NT; Vianna, ME; Zaia, AA, 2005
)
0.33
" In conclusion, at polarity-reversal interval of 24 h, electroremediation combined with activated bamboo charcoal was effective in simultaneous removal of 2,4-DCP and Cd from soil."( Simultaneous removal of 2,4-dichlorophenol and Cd from soils by electrokinetic remediation combined with activated bamboo charcoal.
Huang, ZH; Ma, JW; Wang, FY; Wang, H, 2010
)
0.36
" A broad spectrum of toxic organics in water was efficiently destroyed in the presence of dioxygen in combination with hydrazine hydrate at 150 °C."( Dioxygen in combination with hydrazine: a practical system for degradation of a broad spectrum of toxic organics in water.
Chu, C; Liang, X; Liao, N; Liu, R; Liu, Y; Lu, Q; Shen, J; Tao, J, 2011
)
0.37
"A highly efficient and simple two-step method, electro membrane extraction (EME) followed by low-density solvent based ultrasound-assisted emulsification microextraction (EME-LDS-USAEME) combined with derivatization and analysis by gas chromatography-mass spectrometry (GC-MS), was developed for the determination of trace level chlorophenols in environmental water samples."( Electro membrane extraction followed by low-density solvent based ultrasound-assisted emulsification microextraction combined with derivatization for determining chlorophenols and analysis by gas chromatography-mass spectrometry.
Guo, L; Lee, HK, 2012
)
0.38
"This study presents a new technique, dispersive micro solid phase extraction (DMSPE) combined with headspace solid phase micro-extraction (HS-SPME) for extraction and determination of chlorophenols (CPs) in water and honey samples using a Gas Chromatography-Electron Capture Detector (GC-ECD)."( A novel dispersive micro solid phase extraction using zein nanoparticles as the sorbent combined with headspace solid phase micro-extraction to determine chlorophenols in water and honey samples by GC-ECD.
Amanzadeh, H; Biparva, P; Farhadi, K; Farshid, AA; Matin, AA; Pirkharrati, H; Tajik, H, 2014
)
0.4
"To observe the effects of electroacupuncture (EA) at "Jiaji" (EX-B 2) points combined with nerve mobilization on protein and mRNA expression of RhoA in rabbits with sciatic nerve injury, and to provide theoretical basis for the treatment of peripheral nerve injury by EA at "Jiaji" (EX-B 2) points combined with nerve mobilization."( [Effect of electroacupuncture at "Jiaji" (EX-B 2) points combined with nerve mobilization on motor function and mRNA and protein expression of RhoA in rabbits with sciatic nerve injury].
Dong, CF; Guo, ZN; Wang, Y; Xu, RN; Yuan, YM; Zheng, LL, 2019
)
0.51
"Aerobic biodegradation combined with pyrite-Fenton process was used for the treatment of wastewater containing different chlorophenols (4-CP, 2,3-DCP, 2,4-DCP, 2,4,6-TCP)."( Comparison of treatability of four different chlorophenol-containing wastewater by pyrite-Fenton process combined with aerobic biodegradation: Role of sludge acclimation.
Kantar, C; Kayan, I; Oz, NA, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of chemicals has received considerable attention in aquatic toxicology, and it is generally agreed that information about bioavailability is lacking in many situations."( The perfused fish gill preparation in studies of the bioavailability of chemicals.
Pärt, P, 1990
)
0.28
" The present results indicate that the toxicity and bioaccumulation and therefore the bioavailability of chlorophenols in soil to earthworms are dependent on the concentration in soil solution and can be predicted on the basis of adsorption data."( Toxicity and bioaccumulation of chlorophenols in earthworms, in relation to bioavailability in soil.
Ma, WC; van Gestel, CA, 1988
)
0.27
" The results clearly demonstrate that the differing impact of protein binding on the bioavailability of chemicals considerably influences their nominal and relative potencies in the presence of albumin."( Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration.
Gülden, M; Mörchel, S; Seibert, H, 2002
)
0.31
" The novel bioassay provides a rapid and sensitive method to assess bioavailability of pollutants as well as a method to determine their toxicity to filamentous fungi."( Development of a novel, bioluminescence-based, fungal bioassay for toxicity testing.
Campbell, CD; Killham, K; Weitz, HJ, 2002
)
0.31
" By oxidation and soil washing the biodegradability and bioavailability of these otherwise recalcitrant compounds can be enhanced."( Aged chlorophenol contaminated soil's integrated treatment by ozonation, soil washing and biological methods.
Haapea, P; Tuhkanen, T, 2005
)
0.33
" This research investigated 2,4-dichlorophenol (2,4-DCP) sequestration by the aquatic plant Lemna minor and evaluated contaminant release and bioavailability after plant death and cellular disruption."( Activity of Desulfitobacterium sp. strain Viet1 demonstrates bioavailability of 2,4-dichlorophenol previously sequestered by the aquatic plant Lemna minor.
Amos, BK; Löffler, FE; Saunders, FM; Tront, JM, 2006
)
0.33
" This approach appears to be a promising alternative treatment to reduce 2,4-DCP bioavailability and thus toxicity in the environment."( Reduction of 2,4-dichlorophenol toxicity to Pseudomonas putida after oxidative incubation with humic substances and a biomimetic catalyst.
Armenante, PM; Cozzolino, A; Hahn, D; Piccolo, A, 2007
)
0.34
"The complex and variable composition of natural sediments makes it very difficult to predict the bioavailability and bioaccumulation of sediment-bound contaminants."( Modelling 2,4-dichlorophenol bioavailability and bioaccumulation by the freshwater fingernail clam Sphaerium corneum using artificial particles and humic acids.
Simkiss, K; Taylor, MG; Verrengia Guerrero, NR, 2007
)
0.34
" OMC appeared to be a good trap for PCP with potential applications in remediation technology because it reduces the potential toxicity of PCP to microbial community by lowering its bioavailability and thus facilitates its biodegradation."( Bioremediation of soil contaminated with pentachlorophenol (PCP) using humic acids bound on zeolite.
Barancíková, G; Dercová, K; Makovníková, J; Sejáková, Z; Skokanová, M, 2007
)
0.34
"The bioavailability of pollutants, pesticides and/or their degradation products in soil depends on the strength of their sorption by the different soil components, particularly by the clay minerals."( Sorption and desorption behavior of chloroanilines and chlorophenols on montmorillonite and kaolinite.
Gennaro, MC; Gianotti, V; Gosetti, F; Polati, S, 2006
)
0.33
" The presence of 300 mg l(-1) rhamnolipids, that is at about twice their critical micelle concentration (CMC), increased the EC50 of phenol, 4-chlorophenol, 2,4-dichlorophenol and 2,4,5-trichlorophenol by about 12, 19, 32 and 40%, respectively, and consequently reduced the bioavailability and the freely dissolved concentration of the toxic phenolic compounds."( Rhamnolipid biosurfactants decrease the toxicity of chlorinated phenols to Pseudomonas putida DOT-T1E.
Chrzanowski, L; Heipieper, HJ; Kaestner, M; Meulenkamp, R; Wick, LY, 2009
)
0.35
"Results provide evidence that next to the effect of the micelle formation also hydrophobic interactions with rhamnolipid-based dissolved organic carbon affects the bioavailability of the phenols."( Rhamnolipid biosurfactants decrease the toxicity of chlorinated phenols to Pseudomonas putida DOT-T1E.
Chrzanowski, L; Heipieper, HJ; Kaestner, M; Meulenkamp, R; Wick, LY, 2009
)
0.35
" Our results indicate that geophagous earthworms may change sorption behavior and thus the bioavailability and transport of chlorophenols in soil."( Enhancement of chlorophenol sorption on soil by geophagous earthworms (Metaphire guillelmi).
Cui, Y; Guo, H; Ji, L; Ji, R; Shan, J; Xu, J; Zhou, W, 2011
)
0.37
" The acidic condition of the soil presumably reduces bioavailability of PCP, leading to less pronounced effects than the other pollutants."( Impact of chlorophenols on microbiota of an unpolluted acidic soil: microbial resistance and biodegradation.
Caliz, J; Cruañas, R; Garau, MA; Martí, E; Montserrat, G; Sierra, J; Vila, X, 2011
)
0.37
" The inhibitory effects are supposed to be owing to limited activities of soil endogenous microorganisms, potential toxicities of CNTs to the microorganisms, and reduced bioavailability of 2,4-DCP in the presence of CNTs, even though a desorption hysteresis of 2,4-DCP on CNTs was not observed."( Inhibitory effects of carbon nanotubes on the degradation of 14C-2,4-dichlorophenol in soil.
Feng, J; Guo, H; Ji, R; Jiang, B; Shan, J; Wang, L; Zhou, W, 2013
)
0.39
" The oligomerization and partial dechlorination brought about by grinding, suggest a reduction in bioavailability and toxicity."( Birnessite-induced mechanochemical degradation of 2,4-dichlorophenol.
Mingelgrin, U; Nasser, A, 2014
)
0.4
" This polymeric substance has both hydrophilic and hydrophobic moieties, and it is known that they affect to bioavailability of environmental pollutants."( Toxicological effects of chlorophenols to green algae observed at various pH and concentration of humic acid.
Shoji, R; Suzuki, D, 2020
)
0.56
" This suggests that the dechlorination of CPs with Fenton process, in conjunction with sludge acclimation, not only reduced the sludge toxicity, but also enhanced the bioavailability of CP-containing wastewater for microorganisms, especially for highly chlorinated toxic CPs such as 2,4,6-TCP."( Comparison of treatability of four different chlorophenol-containing wastewater by pyrite-Fenton process combined with aerobic biodegradation: Role of sludge acclimation.
Kantar, C; Kayan, I; Oz, NA, 2021
)
0.62
" CNB shows 88% of oral bioavailability and is responsible for modifying the plasma concentrations of other co-administered ASMs, such as lamotrigine, carbamazepine, phenytoin, phenobarbital and the active metabolite of clobazam."( Development and Validation of a UHPLC-MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples.
Charlier, B; Coglianese, A; Coppola, G; Dal Piaz, F; de Grazia, U; Filippelli, A; Izzo, V; Menna, P; Operto, FF, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" Evolution of (14)CO(2) from active versus poisoned soil dosed with 50 mug of the individual TCBs per g gave conclusive proof that both isomers are biodegradable."( Biodegradation of 1,2,3- and 1,2,4-trichlorobenzene in soil and in liquid enrichment culture.
Bartha, R; Marinucci, AC, 1979
)
0.26
" Comparison of the dose-response curves of the in vivo and in vitro assays indicated that urinary metabolites of lindane provided a good index of phenobarbital-induced change in both phase I and phase II reactions."( Comparison of in vivo and in vitro methods for assessing the effects of phenobarbital on the hepatic drug-metabolizing enzyme system.
Carlson, GP; Chadwick, RW; Copeland, MF; Most, BM; Trela, BA, 1985
)
0.27
" Dosage ranged from 600 to 2,400 mg/day for fengabine and 50 to 200 mg/day for TCAs."( Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
Garreau, M; Magni, G; Orofiamma, B; Palminteri, R, 1989
)
0.28
"2 mmol/kg body wt, twice a day) produced significant elevations in fasting serum glucose levels, but this dosage of 4-CP did not alter serum lipid and lipoprotein parameters, whereas clofibrate significantly reduced serum total cholesterol and high density lipoprotein cholesterol levels."( Pharmacologic effects of 4-chlorophenol in rats: comparison to clofibrate.
Feller, DR; Hanson, JM; Newman, HA; Patel, ST; Phornchirasilp, S; Witiak, DT, 1989
)
0.28
" Replicate streams were dosed continuously at pentachlorophenol concentrations of 0, 48, and 144 micrograms/L, respectively, for an 88-d period during the summer of 1983."( Response of the microflora in outdoor experimental streams to pentachlorophenol: environmental factors.
Carlson, RE; Crawford, RL; Johnson, LK; Martinson, MM; Pignatello, JJ, 1986
)
0.27
" We review here methods used in studies of occupational pesticide exposure, with particular attention to validation in terms of dose-response relationships, to technical complexity and cost, to the requirements for analytical quality control, and to the utility of these methods for field research purposes."( Biological monitoring of agricultural workers exposed to pesticides: II. Monitoring of intact pesticides and their metabolites.
Coye, MJ; Lowe, JA; Maddy, KJ, 1986
)
0.27
" A dose-response relationship was observed for both fibroblasts and bacteria."( A comparison of the antibacterial and cytotoxic effects of parachlorophenol.
Feigal, RJ; Messer, HH, 1985
)
0.27
"After dosing goldfish (Carassius auratus) for 2 hr with pentachloro-2-(chloromethyl sulphonamido) diphenyl ether, 6-PCSD, (the major component of the active ingredients of the mothproofing agent Eulan WA New) in the surrounding water, high concentrations of the corresponding amine pentachloro-2-aminodiphenyl ether, 5-PAD, were found in the liver."( The in vitro metabolism by homogenates of goldfish (Carassius auratus) liver of pentachloro-2-(chloromethyl sulphonamido) diphenyl ether, the major component and active ingredient of the mothproofing agent Eulan WA New.
Machon, A; North, MJ; Price, NC; Wells, DE, 1984
)
0.27
" The channels were dosed continuously during the summer of 1982 with various concentrations of PCP (approximately 0, 48, 144, and 432 micrograms/liter)."( Biodegradation and photolysis of pentachlorophenol in artificial freshwater streams.
Carlson, RE; Crawford, RL; Martinson, MM; Pignatello, JJ; Steiert, JG, 1983
)
0.27
" Oral dosing of calves with PCP in capsules--0."( Plasma pentachlorophenol concentrations in calves exposed to treated wood in the environment.
Olesen, B; Osweiler, GD; Rottinghaus, GE, 1984
)
0.27
" Four hours after dosing the animals were sacrificed and hepatic DNA was isolated."( Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
Beland, FA; Meerman, JH; Mulder, GJ, 1981
)
0.26
" The dose-response curves by HCP and PCP were sigmoidal, indicating cooperative inhibition, while those by 2,4,5-TCP and 2,4,6-TCP were not."( Cooperative inhibition of acetylcholinesterase activities by hexachlorophene in human erythrocytes.
Igisu, H; Ikeda, M; Matsumura, H; Matsuoka, M, 1997
)
0.3
" In both antibiotic-pretreated and bile duct-cannulated rats dosed with o-DCB, the concentrations of 2,3- and 3,4-DCPSO2Mes in blood, liver, kidneys, and adipose tissue were dramatically reduced."( Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
Kato, Y; Kimura, R, 1997
)
0.3
" The maximum toxicity normally occurred before the maximum color intensity was monitored, while ozone dosage applied was within 1 mg of ozone per mg of initial CPs."( Variation of toxicity during the ozonation of monochlorophenolic solutions.
Ma, HW; Shang, NC; Yu, YH, 2002
)
0.31
" variegatus expressed a dose-response sediment avoidance behaviour but the PCP tissue concentrations were not affected by this behaviour."( Toxicokinetics, toxicity and lethal body residues of two chlorophenols in the oligochaete worm, Lumbriculus variegatus, in different sediments.
Halme, A; Kukkonen, JV; Nikkilä, A, 2003
)
0.32
" The effect of silica dosage (1, 5, 10, and 20 g/L), peroxide dosage (60, 75, and 100 mg/L), and pH (3, 7, and 11) is examined."( Heterogeneous ultrasonic destruction of aqueous organic contaminants.
Kamrajapuram, A; Suri, RP, 2003
)
0.32
"Experiments have established the high efficacy of combinations of the micronized dosage form of trichlorophen, with albendazole or medamine in treating trichocephaliasis (its causative agent being Trichocephalus muris) in DBA/2st mice and that of trichlorophen in combination with azinox or fenasal in outbred albino mice with hymenolepiasis (its causative agent being Hymenolepis nana)."( [Efficacy of the Russian anthelmintic agent trichlorophen].
Astaf'ev, BA; Fedianina, LV; Gitsu, GA; Lebedeva, MN,
)
0.13
" The influence of initial concentration and adsorbent dosage was studied."( Sorption of phenol and 4-chlorophenol onto pumice treated with cationic surfactant.
Akbal, F, 2005
)
0.33
" The influence of some operating conditions such as temperature, dosage of hydrogen peroxide and initial concentration of the chlorophenols was studied in absence of a catalyst."( Wet peroxide oxidation of chlorophenols.
Chamarro, E; Esplugas, S; Florczyk, M; García-Molina, V; López-Arias, M, 2005
)
0.33
" Several factors affecting the degradation of 4CP by MW/UV/TiO2 method, such as the dosage of photocatalysts, the initial pH value of the solutions, gas bubbling, light intensity and addition of H2O2 oxidant, were studied in detail."( Degradation of 4-chlorophenol by a microwave assisted photocatalysis method.
Ai, Z; Lu, X; Yang, P, 2005
)
0.33
" The largest inhibition of OUR appeared at one mol of applied ozone dosage per mol of initial 2-CP, and the percentage of inhibition was 63."( Toxicity measurements in aqueous solution during ozonation of mono-chlorophenols.
Chang, CH; Liou, ML; Ma, HW; Shang, NC; Yu, YH, 2006
)
0.33
" Channel catfish (Ictalurus punctatus) were dosed with mixtures of benzo[a]pyrene and cadmium, chlorinated phenols or borneol."( Heme oxygenase induction and biliverdin excretion: implications for the bile fluorescence biomarker.
van den Hurk, P, 2006
)
0.33
" Comparisons were made with the general BC population and dose-response relationships were assessed using Poisson regression."( Cancer and occupational exposure to pentachlorophenol and tetrachlorophenol (Canada).
Davies, HW; Demers, PA; Friesen, MC; Hershler, R; Hertzman, C; Ostry, A; Teschke, K, 2006
)
0.33
" Internal analyses showed strong dose-response relationships for non-Hodgkin's lymphoma, multiple myeloma, and kidney cancer."( Cancer and occupational exposure to pentachlorophenol and tetrachlorophenol (Canada).
Davies, HW; Demers, PA; Friesen, MC; Hershler, R; Hertzman, C; Ostry, A; Teschke, K, 2006
)
0.33
" Modeling results revealed that the empirical pathway was capable of predicting the ozonation reaction at the beginning phase under a higher ozone dosage (e."( Kinetics of the degradation of 2-chlorophenol by ozonation at pH 3.
Huang, CP; Sung, M, 2007
)
0.34
"This paper presents a simple, specific, and precise high-performance liquid chromatographic method for the simultaneous determination of paracetamol (PCM), chlorzoxazone (CXZ), and their related impurities in bulk raw materials and solid dosage forms."( Simultaneous determination of paracetamol, chlorzoxazone, and related impurities 4-aminophenol, 4'-chloroacetanilide, and p-chlorophenol in pharmaceutical preparations by high-performance liquid chromatography.
Ali, MS; Ghori, M; Kahtri, AR; Rafiuddin, S,
)
0.13
" Where possible, the response of soils to the contaminant was modelled by a sigmoidal dose-response curve in order to estimate the ED(50) values."( Evaluation of various tests for the diagnosis of soil contamination by 2,4,5-trichlorophenol (2,4,5-TCP).
Bello, D; Gil-Sotres, F; Leirós, MC; Trasar-Cepeda, C, 2008
)
0.35
" Differences in granules shape and size were observed with 4CP and TCP dosed in the influent, and the effects of such toxic compounds on acetate removal were evaluated."( Acetate-fed aerobic granular sludge for the degradation of chlorinated phenols.
Carucci, A; De Gioannis, G; Milia, S; Piredda, M, 2008
)
0.35
" Differences in granules shape and size were observed with 4CP dosed in the influent at different concentrations, and the effects of such toxic compound on acetate removal were evaluated, with both unacclimated and acclimated biomass."( Acetate-fed aerobic granular sludge for the degradation of 4-chlorophenol.
Carucci, A; De Gioannis, G; Milia, S; Piredda, M, 2009
)
0.35
" Basically, increasing initial H(2)O(2) dosage was much more beneficial for increasing biodegradability of wastewater than increasing initial Fe(2 + ) dosage."( Biodegradability of chlorophenol wastewater enhanced by solar photo-Fenton process.
Kuo, WS; Lin, IT, 2009
)
0.35
" To perform the immediate effect analysis (GPi or zero time), of each mixture either at room or refrigerator temperature, the preparation procedure was similar, although GPR, iodoform, Rifocort and camphorated paramonochlorophenol were stored in the refrigerator and then taken out, dosed and manipulated, and had their immediate effect tested after a 1-week period at storage of 4 degrees C average temperature."( Antimicrobial action of a filling paste used in pulp therapy in primary teeth under different storage conditions.
Ferreira, FV; Friedrich, RS; Guedes-Pinto, AC; Praetzel, JR; Weiss, RN, 2008
)
0.35
" A conventional Sequencing Batch Reactor (SBR) and a Membrane BioReactor (MBR) were operated in parallel under the same 4CP influent concentrations and/or 4CP volumetric organic loading rates as the GSBR, in order to carry out a direct comparison in terms of 4CP removal efficiencies and specific removal rates, effluent quality, waste sludge production, system simplicity, land area requirement, start-up times, NaAc dosage as growth substrate and maximum applied 4CP volumetric organic loading rate."( A direct comparison amongst different technologies (aerobic granular sludge, SBR and MBR) for the treatment of wastewater contaminated by 4-chlorophenol.
Cappai, G; Carucci, A; Milia, S; Muntoni, A, 2010
)
0.36
"2, the dosage of chlorine dioxide is 1000 mg/l, the dosage of activated carbon-MnO(2) catalyst is 6g by reacting 60 min."( Catalytic oxidation and spectroscopic analysis of simulated wastewater containing o-chlorophenol by using chlorine dioxide as oxidant.
Li, N; Shi, L; Wang, C, 2010
)
0.36
" With the increase of the dosage of 2,4-dichlorophenol, stepwise improvement of biomass bioactivity and the reduction in activated sludge production were achieved simultaneously."( Impact of a metabolic uncoupler, 2,4-dichlorophenol on minimization of activated sludge production in membrane bioreactor.
Qiong, T; Song, L; Wenju, J; Yaozhong, L, 2010
)
0.36
" The effects of different 4CP/NaAc ratios on SBR performances were evaluated in terms of 4CP removal efficiencies and maximum specific removal rates in order to maximize reactor performances: a decrease in NaAc dosage as external growth substrate would lead to definitely lower operating costs."( Effects of the cometabolite/growth substrate ratio on the aerobic degradation of 4-monochlorophenol.
Cappai, G; Carucci, A; De Gioannis, G; Milia, S, 2011
)
0.37
" The effect of experimental parameters such as contact time, effect of pH (2-10), initial concentration of adsorbate (50-200 mg L(-1)) and amount of biosorbent dosage was evaluated."( Equilibrium and kinetic studies on biosorption of 2,4,6-trichlorophenol from aqueous solutions by Acacia leucocephala bark.
Kumar, NS; Min, K; Woo, HS, 2012
)
0.38
" Enhancement in the rate of bioregeneration was achieved by using the lowest ratio under either one of the following experimental conditions: (1) increasing initial chlorophenol concentration at constant GAC dosage and (2) increasing GAC dosage at constant initial chlorophenol concentration."( Kinetic modeling of bioregeneration of chlorophenol-loaded granular activated carbon in simultaneous adsorption and biodegradation processes.
Lim, PE; Oh, WD; Seng, CE; Sujari, AN, 2012
)
0.38
" The effect of pH, catalyst dosage and dissolved iron on the degradation efficiency were studied."( [Degradation of organic pollutants by photo-Fenton-like system with hematite].
Gu, Y; He, Y; Huang, YP; Li, RP; Yang, H; Zhang, AQ; Zhang, Y, 2012
)
0.38
" The effects of reaction time, pH, temperature, chlorophenol concentration, and laccase dosage on the removal efficiency of chlorophenols were investigated."( [Condition optimization for degradation of chlorophenols using laccase from Amillariella mellea].
Qin, RB; Wu, K; Zhang, JJ; Zhao, HK; Zhu, XF, 2012
)
0.38
"0 g L(-1) nFe(3)O(4) was the optimal dosage in the presence of 3 g L(-1) Pd/Fe nanoparticles in our system, removing 76."( Enhanced dechlorination of 2,4-dichlorophenol by Pd/FeFe3O4 nanocomposites.
Baig, SA; Lv, X; Tang, J; Xu, J; Xu, X, 2013
)
0.39
" Response surface methodology (RSM) was employed to obtain the optimal dosage of the combined uncoupler."( Treatability study of 3,3',4',5-tetrachlorosalicylanilide (TCS) combined with 2,4,6-trichlorophenol (TCP) to reduce excess sludge production in a sequence batch reactor.
Chen, C; Du, JS; Feng, XC; Guo, WQ; Jin, WB; Liu, B; Ren, NQ; Yang, SS; Zheng, HS, 2013
)
0.39
"04 4 wt% and catalyst dosage of 5 g L(-1), TCBPA with an initial concentration of 20 μM was completely transformed within 60 min, and BPA was detected as the major product through the reaction time."( Reductive dechlorination of tetrachlorobisphenol A by Pd/Fe bimetallic catalysts.
Huang, Q; Huang, W; Liu, W; Peng, P, 2013
)
0.39
" The degradation of 2-CP was affected by solution pH, light intensity, photocatalyst dosage and 2-CP initial concentration."( InVO4/TiO2 composite for visible-light photocatalytic degradation of 2-chlorophenol in wastewater.
Barakat, MA; Kuhn, JN; Pettit, SL; Rashid, J,
)
0.13
" In contrast, for H2O2 dosing (proportional continuous or cumulative one-time), the flow rate did not significantly affect process efficacy."( A highly effective photochemical system for complex treatment of heavily contaminated wastewaters.
Hejda, S; Kluson, P; Krystynik, P; Masin, P; Tito, DN, 2014
)
0.4
" The critical effect of ox dosing was confirmed with the reactive species of [Fe(II)(ox)0] and [Fe(II)(ox)2 (2-)]."( Oxalate-assisted oxidative degradation of 4-chlorophenol in a bimetallic, zero-valent iron-aluminum/air/water system.
Fan, J; Ma, L; Wang, H, 2016
)
0.43
" To determine the best way to select predictive groups of genes, we used published microarray data from dose-response studies on six chemicals in rats exposed orally for 5, 14, 28, and 90 days."( Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment.
Barton-Maclaren, TS; Chepelev, NL; Curran, IH; Farmahin, R; Kuo, B; Nong, A; Thomas, RS; Wade, MG; Williams, A; Yauk, CL, 2017
)
0.46
" Therefore, we adapted a passive dosing format to test the toxicity of BCP at different concentrations and in multiple test systems with aquatic organisms of various trophic levels."( Improving the reliability of aquatic toxicity testing of hydrophobic chemicals via equilibrium passive dosing - A multiple trophic level case study on bromochlorophene.
Ewald, F; Hollert, H; Miller, I; Schäffer, A; Stibany, F, 2017
)
0.46
" In addition, the removal kinetics of 2,4-DCP by Fe-Ni/CNTs were in agreement with a pseudo-first-order model, and the rate constants were dependent on a number of factors including the initial concentration of 2,4-DCP, the dosage of Fe-Ni/CNTs, pH value of the solution, and doping amount of Ni."( Synergistic effect and degradation mechanism on Fe-Ni/CNTs for removal of 2,4-dichlorophenol in aqueous solution.
Chun, Y; Fei, Z; Li, C; Liu, Z; Sun, Y; Zhang, A, 2019
)
0.51
"50%, respectively, when dosing 5, 10, 15, and 20 mg/L oCP."( Formation of microbial products by activated sludge in the presence of a metabolic uncoupler o-chlorophenol in long-term operated sequencing batch reactors.
Cao, JS; Dong, JY; Fang, F; Li, KY; Wang, SN; Xie, WM; Xu, RZ; Zhang, LL, 2020
)
0.56
" The results indicated that excessive carbon amounts inhibited 2,4,6-TCP degradation in the long-term operation and a typical cycle, while a suitable dosage could increase the removal of 2,4,6-TCP."( Exploring the effects of carbon source level on the degradation of 2,4,6-trichlorophenol in the co-metabolism process.
Sun, Z; Wang, J, 2020
)
0.56
" Cenobamate demonstrated significant efficacy at a dosage between 100 and 400 mg per day."( Cenobamate for the treatment of focal epilepsies.
Bauer, S; Mann, C; Rosenow, F; Strzelczyk, A; Willems, LM, 2020
)
0.56
" Increased dosage of cenobamate across 150-400 mg/day range was significantly associated with higher responder rates (p < 0."( Cenobamate treatment of focal-onset seizures: Quality of life and outcome during up to eight years of treatment.
Coe, P; Elizebath, R; Gutierrez, EG; Krauss, GL; Yang, J; Zhang, E, 2021
)
0.62
" Surprisingly, 2,6-DCP has certain biodegradability and could be used as an environmentally friendly metabolic uncoupler under low-concentration dosing conditions."( Insight investigation of the on-site activated sludge reduction induced by metabolic uncoupler: Effects of 2,6-dichlorophenol on soluble microbial products, microbial activity, and environmental impact.
Li, L; Lin, Q; Tian, Y; Yin, L; Zhang, J; Zuo, W, 2022
)
0.72
" We evaluated dosage and serum levels, efficacy, drug interactions, and adverse effects."( Initial Real-World Experience With Cenobamate in Adolescents and Adults: A Single Center Experience.
Elliott, T; Gienapp, AJ; Ridley-Pryor, T; Wheless, JW, 2022
)
0.72
"After gradually increasing cenobamate to clinical effect using the FDA-approved dosing protocol, 60% (n = 22) of patients were responders."( Initial Real-World Experience With Cenobamate in Adolescents and Adults: A Single Center Experience.
Elliott, T; Gienapp, AJ; Ridley-Pryor, T; Wheless, JW, 2022
)
0.72
" Dosing oCP stimulated the formation of microbial products and increased the DNA concentration, but resulted in a decrease in the electronic transport activity of activated sludge."( Sludge reduction and microbial community evolution of activated sludge induced by metabolic uncoupler o-chlorophenol in long-term anaerobic-oxic process.
Cao, JS; Fang, F; Li, KY; Luo, JY; Ni, BJ; Wang, SN; Xu, RZ; Yue, YR, 2022
)
0.72
" The aim of this study was to develop and validate, according to the most recent guidelines, an analytical method using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) to evaluate CNB dosage in plasma samples."( Development and Validation of a UHPLC-MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples.
Charlier, B; Coglianese, A; Coppola, G; Dal Piaz, F; de Grazia, U; Filippelli, A; Izzo, V; Menna, P; Operto, FF, 2022
)
0.72
" There were clear dose-response relations for all investigated parameters."( Excretion kinetics of 1,3-dichlorobenzene and its urinary metabolites after controlled airborne exposure in human volunteers.
Bertram, J; Christoforou, R; Esser, A; Krabbe, J; Kraus, T; Möller, M; Schettgen, T; Schweiker, M; Ziegler, P, 2023
)
0.91
" Experimental parameters such as temperature, dosage of CPs and SFN structure have shown to have a major effect in the CP removal efficiency."( Spinel ferrite nanoparticles as potential materials in chlorophenol removal from wastewater.
Al-Najar, B; Albuflasa, H; Hankins, NP; Kamel, AH, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
tetrachlorophenolA chlorophenol that is phenol in which four of the hydrogens attached to the benzene ring are replaced by chlorines.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (35)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency35.71680.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency35.71680.025120.237639.8107AID886; AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency89.35840.007215.758889.3584AID1224835
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
RAR-related orphan receptor gammaMus musculus (house mouse)Potency55.77620.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency37.12440.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency49.26650.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID743035; AID743036; AID743042; AID743053; AID743054; AID743063
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency9.55940.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency21.22760.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency46.81820.000417.946075.1148AID1346784; AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency38.26420.000214.376460.0339AID588532; AID588533; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency47.83790.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency19.02040.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency54.86510.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency30.91160.375827.485161.6524AID588526; AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency52.99280.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency44.47250.000229.305416,493.5996AID1259244; AID1259248; AID588513; AID588514; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency34.89370.001024.504861.6448AID588534; AID588535
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency29.10180.001019.414170.9645AID588537; AID743094; AID743191
aryl hydrocarbon receptorHomo sapiens (human)Potency44.98590.000723.06741,258.9301AID651777; AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency34.37620.001723.839378.1014AID743083
Histone H2A.xCricetulus griseus (Chinese hamster)Potency113.88330.039147.5451146.8240AID1224845; AID1224896
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency8.91250.001815.663839.8107AID894
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency39.90370.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency32.42680.042027.378961.6448AID743210
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID995
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency45.44770.000627.21521,122.0200AID651741; AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency54.32660.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency39.84030.002319.595674.0614AID651631; AID651743; AID720552
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency54.32660.001551.739315,848.9004AID1259244
Nuclear receptor ROR-gammaHomo sapiens (human)Potency33.49150.026622.448266.8242AID651802
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)Potency44.66840.015823.527344.6684AID651778
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency49.28710.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency49.28710.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (195)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of hepatocyte apoptotic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of ATP biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transformation of host cell by virusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to hypoxiaPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
heart developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
epidermis developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to starvationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of cellular ketone metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid beta-oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of appetitePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to insulinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
circadian regulation of gene expressionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
behavioral response to nicotinePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipoprotein metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to ethanolPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of blood pressurePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of glycolytic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nitric oxide metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
enamel mineralizationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to fructose stimulusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid transportPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (56)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
phosphatase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein domain specific bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
ubiquitin conjugating enzyme bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein-containing complex bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
NFAT protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
MDM2/MDM4 family protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3,379)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990642 (19.00)18.7374
1990's394 (11.66)18.2507
2000's1093 (32.35)29.6817
2010's979 (28.97)24.3611
2020's271 (8.02)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.18 (24.57)
Research Supply Index8.18 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials37 (1.04%)5.53%
Reviews90 (2.54%)6.00%
Case Studies37 (1.04%)4.05%
Observational0 (0.00%)0.25%
Other3,382 (95.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]